Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Encheng Zhang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Aging|April 9, 2021
Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinomaXiao Dong, Yang Han, Encheng Zhang, et al.
Epigenetics|March 23, 2023
Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progressionHeting Tang, Yaping Guan, Zhihao Yuan, et al.
Cancer Science|November 3, 2023
KDM4B: A promising oncology therapeutic targetFangjing Ni, Heting Tang, Siteng Cheng, et al.
British Journal of Cancer|November 26, 2021
Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinomaSiteng Chen, Liren Jiang, Feng Gao, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|May 17, 2025
Trichothecenes toxicity in humans and animals: Unraveling the mechanisms and harnessing phytochemicals for preventionJiexing Zhang, Haoyan Li, Encheng Zhang, et al.
Heliyon|September 26, 2022
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinomaSiteng Chen, Tuanjie Guo, Encheng Zhang, et al.
Cancer Science|May 1, 2021
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancerSiteng Chen, Liren Jiang, Xinyi Zheng, et al.
Frontiers in Immunology|February 24, 2022
Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning AlgorithmSiteng Chen, Encheng Zhang, Liren Jiang, et al.
Frontiers in Oncology|July 5, 2021
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer PatientsSiteng Chen, Liren Jiang, Encheng Zhang, et al.
International Journal of Cancer|September 8, 2020
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinomaSiteng Chen, Ning Zhang, Liren Jiang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Aging|April 9, 2021
Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinomaXiao Dong, Yang Han, Encheng Zhang, et al.
Epigenetics|March 23, 2023
Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progressionHeting Tang, Yaping Guan, Zhihao Yuan, et al.
Cancer Science|November 3, 2023
KDM4B: A promising oncology therapeutic targetFangjing Ni, Heting Tang, Siteng Cheng, et al.
British Journal of Cancer|November 26, 2021
Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinomaSiteng Chen, Liren Jiang, Feng Gao, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|May 17, 2025
Trichothecenes toxicity in humans and animals: Unraveling the mechanisms and harnessing phytochemicals for preventionJiexing Zhang, Haoyan Li, Encheng Zhang, et al.
Heliyon|September 26, 2022
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinomaSiteng Chen, Tuanjie Guo, Encheng Zhang, et al.
Cancer Science|May 1, 2021
Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancerSiteng Chen, Liren Jiang, Xinyi Zheng, et al.
Frontiers in Immunology|February 24, 2022
Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell Carcinoma Through Deep Learning AlgorithmSiteng Chen, Encheng Zhang, Liren Jiang, et al.
Frontiers in Oncology|July 5, 2021
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer PatientsSiteng Chen, Liren Jiang, Encheng Zhang, et al.
International Journal of Cancer|September 8, 2020
Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinomaSiteng Chen, Ning Zhang, Liren Jiang, et al.
Pageof 3